Ex-Valeant Official Says He Suspected Secret Financial Stake
- Jury hears taped conversation with drug company’s former CEO
- Case reveals ties with mail-order pharmacy to boost sales
Photographer: Andrey Rudakov/Bloomberg
This article is for subscribers only.
A former Valeant Pharmaceuticals International Inc. executive told a jury how he became concerned that one of his senior directors had a secret financial interest in a mail-order pharmacy that did business with the drug company.
Laizer Kornwasser, one the government’s star witnesses in the fraud and money-laundering trial of Gary Tanner and Andrew Davenport, the former head of Philidor Rx Services LLC, took the witness stand Monday in Manhattan federal court. He said Tanner wasn’t following through on his responsibility to find additional mail-order pharmacies with which Valeant could do business, suggesting he wanted to keep all of the business at Philidor.